Request for Covid-19 Impact Assessment of this Report
The United States Prescription Weight Loss Medications market is expected at value of US$ million in 2021 and grow at approximately % CAGR during forecast period 2022-2028. China constitutes a % market for the global Prescription Weight Loss Medications market, reaching US$ million by the year 2028. As for the Europe Prescription Weight Loss Medications landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 6-year period.
Global main Prescription Weight Loss Medications players cover Pfizer, Bristol-Myers Squibb, Roche, and Novo Nordisk, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Prescription Weight Loss Medications market by product type, application, key manufacturers and key regions and countries.
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Children & Teenagers
Adults
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Online Sales
Offline Sales
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Pfizer
Bristol-Myers Squibb
Roche
Novo Nordisk
GlaxoSmithKline
Vivus
Currax Pharmaceuticals
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Prescription Weight Loss Medications Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Prescription Weight Loss Medications by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Prescription Weight Loss Medications by Country/Region, 2017, 2022 & 2028
2.2 Prescription Weight Loss Medications Segment by Application
2.2.1 Children & Teenagers
2.2.2 Adults
2.3 Prescription Weight Loss Medications Sales by Application
2.3.1 Global Prescription Weight Loss Medications Sales Market Share by Application (2017-2022)
2.3.2 Global Prescription Weight Loss Medications Revenue and Market Share by Application (2017-2022)
2.3.3 Global Prescription Weight Loss Medications Sale Price by Application (2017-2022)
2.4 Prescription Weight Loss Medications Segment by Sales Channel
2.4.1 Online Sales
2.4.2 Offline Sales
2.5 Prescription Weight Loss Medications Sales by Sales Channel
2.5.1 Global Prescription Weight Loss Medications Sale Market Share by Sales Channel (2017-2022)
2.5.2 Global Prescription Weight Loss Medications Revenue and Market Share by Sales Channel (2017-2022)
2.5.3 Global Prescription Weight Loss Medications Sale Price by Sales Channel (2017-2022)
3 Global Prescription Weight Loss Medications by Company
3.1 Global Prescription Weight Loss Medications Breakdown Data by Company
3.1.1 Global Prescription Weight Loss Medications Annual Sales by Company (2020-2022)
3.1.2 Global Prescription Weight Loss Medications Sales Market Share by Company (2020-2022)
3.2 Global Prescription Weight Loss Medications Annual Revenue by Company (2020-2022)
3.2.1 Global Prescription Weight Loss Medications Revenue by Company (2020-2022)
3.2.2 Global Prescription Weight Loss Medications Revenue Market Share by Company (2020-2022)
3.3 Global Prescription Weight Loss Medications Sale Price by Company
3.4 Key Manufacturers Prescription Weight Loss Medications Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Prescription Weight Loss Medications Product Location Distribution
3.4.2 Players Prescription Weight Loss Medications Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Prescription Weight Loss Medications by Geographic Region
4.1 World Historic Prescription Weight Loss Medications Market Size by Geographic Region (2017-2022)
4.1.1 Global Prescription Weight Loss Medications Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Prescription Weight Loss Medications Annual Revenue by Geographic Region
4.2 World Historic Prescription Weight Loss Medications Market Size by Country/Region (2017-2022)
4.2.1 Global Prescription Weight Loss Medications Annual Sales by Country/Region (2017-2022)
4.2.2 Global Prescription Weight Loss Medications Annual Revenue by Country/Region
4.3 Americas Prescription Weight Loss Medications Sales Growth
4.4 APAC Prescription Weight Loss Medications Sales Growth
4.5 Europe Prescription Weight Loss Medications Sales Growth
4.6 Middle East & Africa Prescription Weight Loss Medications Sales Growth
5 Americas
5.1 Americas Prescription Weight Loss Medications Sales by Country
5.1.1 Americas Prescription Weight Loss Medications Sales by Country (2017-2022)
5.1.2 Americas Prescription Weight Loss Medications Revenue by Country (2017-2022)
5.2 Americas Prescription Weight Loss Medications Sales by Application
5.3 Americas Prescription Weight Loss Medications Sales by Sales Channel
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Prescription Weight Loss Medications Sales by Region
6.1.1 APAC Prescription Weight Loss Medications Sales by Region (2017-2022)
6.1.2 APAC Prescription Weight Loss Medications Revenue by Region (2017-2022)
6.2 APAC Prescription Weight Loss Medications Sales by Application
6.3 APAC Prescription Weight Loss Medications Sales by Sales Channel
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Prescription Weight Loss Medications by Country
7.1.1 Europe Prescription Weight Loss Medications Sales by Country (2017-2022)
7.1.2 Europe Prescription Weight Loss Medications Revenue by Country (2017-2022)
7.2 Europe Prescription Weight Loss Medications Sales by Application
7.3 Europe Prescription Weight Loss Medications Sales by Sales Channel
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Prescription Weight Loss Medications by Country
8.1.1 Middle East & Africa Prescription Weight Loss Medications Sales by Country (2017-2022)
8.1.2 Middle East & Africa Prescription Weight Loss Medications Revenue by Country (2017-2022)
8.2 Middle East & Africa Prescription Weight Loss Medications Sales by Application
8.3 Middle East & Africa Prescription Weight Loss Medications Sales by Sales Channel
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Prescription Weight Loss Medications
10.3 Manufacturing Process Analysis of Prescription Weight Loss Medications
10.4 Industry Chain Structure of Prescription Weight Loss Medications
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Prescription Weight Loss Medications Distributors
11.3 Prescription Weight Loss Medications Customer
12 World Forecast Review for Prescription Weight Loss Medications by Geographic Region
12.1 Global Prescription Weight Loss Medications Market Size Forecast by Region
12.1.1 Global Prescription Weight Loss Medications Forecast by Region (2023-2028)
12.1.2 Global Prescription Weight Loss Medications Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Prescription Weight Loss Medications Forecast by Application
12.7 Global Prescription Weight Loss Medications Forecast by Sales Channel
13 Key Players Analysis
13.1 Pfizer
13.1.1 Pfizer Company Information
13.1.2 Pfizer Prescription Weight Loss Medications Product Offered
13.1.3 Pfizer Prescription Weight Loss Medications Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Pfizer Main Business Overview
13.1.5 Pfizer Latest Developments
13.2 Bristol-Myers Squibb
13.2.1 Bristol-Myers Squibb Company Information
13.2.2 Bristol-Myers Squibb Prescription Weight Loss Medications Product Offered
13.2.3 Bristol-Myers Squibb Prescription Weight Loss Medications Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Bristol-Myers Squibb Main Business Overview
13.2.5 Bristol-Myers Squibb Latest Developments
13.3 Roche
13.3.1 Roche Company Information
13.3.2 Roche Prescription Weight Loss Medications Product Offered
13.3.3 Roche Prescription Weight Loss Medications Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Roche Main Business Overview
13.3.5 Roche Latest Developments
13.4 Novo Nordisk
13.4.1 Novo Nordisk Company Information
13.4.2 Novo Nordisk Prescription Weight Loss Medications Product Offered
13.4.3 Novo Nordisk Prescription Weight Loss Medications Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Novo Nordisk Main Business Overview
13.4.5 Novo Nordisk Latest Developments
13.5 GlaxoSmithKline
13.5.1 GlaxoSmithKline Company Information
13.5.2 GlaxoSmithKline Prescription Weight Loss Medications Product Offered
13.5.3 GlaxoSmithKline Prescription Weight Loss Medications Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 GlaxoSmithKline Main Business Overview
13.5.5 GlaxoSmithKline Latest Developments
13.6 Vivus
13.6.1 Vivus Company Information
13.6.2 Vivus Prescription Weight Loss Medications Product Offered
13.6.3 Vivus Prescription Weight Loss Medications Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Vivus Main Business Overview
13.6.5 Vivus Latest Developments
13.7 Currax Pharmaceuticals
13.7.1 Currax Pharmaceuticals Company Information
13.7.2 Currax Pharmaceuticals Prescription Weight Loss Medications Product Offered
13.7.3 Currax Pharmaceuticals Prescription Weight Loss Medications Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Currax Pharmaceuticals Main Business Overview
13.7.5 Currax Pharmaceuticals Latest Developments
14 Research Findings and Conclusion
Table 1. Prescription Weight Loss Medications Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Prescription Weight Loss Medications Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Children & Teenagers
Table 4. Major Players of Adults
Table 5. Global Prescription Weight Loss Medications Sales by Application (2017-2022) & (Units)
Table 6. Global Prescription Weight Loss Medications Sales Market Share by Application (2017-2022)
Table 7. Global Prescription Weight Loss Medications Revenue by Application (2017-2022) & ($ million)
Table 8. Global Prescription Weight Loss Medications Revenue Market Share by Application (2017-2022)
Table 9. Global Prescription Weight Loss Medications Sale Price by Application (2017-2022) & (US$/Unit)
Table 10. Global Prescription Weight Loss Medications Sales by Sales Channel (2017-2022) & (Units)
Table 11. Global Prescription Weight Loss Medications Sales Market Share by Sales Channel (2017-2022)
Table 12. Global Prescription Weight Loss Medications Revenue by Sales Channel (2017-2022)
Table 13. Global Prescription Weight Loss Medications Revenue Market Share by Sales Channel (2017-2022)
Table 14. Global Prescription Weight Loss Medications Sale Price by Sales Channel (2017-2022) & (US$/Unit)
Table 15. Global Prescription Weight Loss Medications Sales by Company (2020-2022) & (Units)
Table 16. Global Prescription Weight Loss Medications Sales Market Share by Company (2020-2022)
Table 17. Global Prescription Weight Loss Medications Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Prescription Weight Loss Medications Revenue Market Share by Company (2020-2022)
Table 19. Global Prescription Weight Loss Medications Sale Price by Company (2020-2022) & (US$/Unit)
Table 20. Key Manufacturers Prescription Weight Loss Medications Producing Area Distribution and Sales Area
Table 21. Players Prescription Weight Loss Medications Products Offered
Table 22. Prescription Weight Loss Medications Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Prescription Weight Loss Medications Sales by Geographic Region (2017-2022) & (Units)
Table 26. Global Prescription Weight Loss Medications Sales Market Share Geographic Region (2017-2022)
Table 27. Global Prescription Weight Loss Medications Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Prescription Weight Loss Medications Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Prescription Weight Loss Medications Sales by Country/Region (2017-2022) & (Units)
Table 30. Global Prescription Weight Loss Medications Sales Market Share by Country/Region (2017-2022)
Table 31. Global Prescription Weight Loss Medications Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Prescription Weight Loss Medications Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Prescription Weight Loss Medications Sales by Country (2017-2022) & (Units)
Table 34. Americas Prescription Weight Loss Medications Sales Market Share by Country (2017-2022)
Table 35. Americas Prescription Weight Loss Medications Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Prescription Weight Loss Medications Revenue Market Share by Country (2017-2022)
Table 37. Americas Prescription Weight Loss Medications Sales by Type (2017-2022) & (Units)
Table 38. Americas Prescription Weight Loss Medications Sales Market Share by Application (2017-2022)
Table 39. Americas Prescription Weight Loss Medications Sales by Sales Channel (2017-2022) & (Units)
Table 40. Americas Prescription Weight Loss Medications Sales Market Share by Sales Channel (2017-2022)
Table 41. APAC Prescription Weight Loss Medications Sales by Region (2017-2022) & (Units)
Table 42. APAC Prescription Weight Loss Medications Sales Market Share by Region (2017-2022)
Table 43. APAC Prescription Weight Loss Medications Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Prescription Weight Loss Medications Revenue Market Share by Region (2017-2022)
Table 45. APAC Prescription Weight Loss Medications Sales by Application (2017-2022) & (Units)
Table 46. APAC Prescription Weight Loss Medications Sales Market Share by Application (2017-2022)
Table 47. APAC Prescription Weight Loss Medications Sales by Sales Channel (2017-2022) & (Units)
Table 48. APAC Prescription Weight Loss Medications Sales Market Share by Sales Channel (2017-2022)
Table 49. Europe Prescription Weight Loss Medications Sales by Country (2017-2022) & (Units)
Table 50. Europe Prescription Weight Loss Medications Sales Market Share by Country (2017-2022)
Table 51. Europe Prescription Weight Loss Medications Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Prescription Weight Loss Medications Revenue Market Share by Country (2017-2022)
Table 53. Europe Prescription Weight Loss Medications Sales by Type (2017-2022) & (Units)
Table 54. Europe Prescription Weight Loss Medications Sales Market Share by Application (2017-2022)
Table 55. Europe Prescription Weight Loss Medications Sales by Sales Channel (2017-2022) & (Units)
Table 56. Europe Prescription Weight Loss Medications Sales Market Share by Sales Channel (2017-2022)
Table 57. Middle East & Africa Prescription Weight Loss Medications Sales by Country (2017-2022) & (Units)
Table 58. Middle East & Africa Prescription Weight Loss Medications Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Prescription Weight Loss Medications Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Prescription Weight Loss Medications Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Prescription Weight Loss Medications Sales by Application (2017-2022) & (Units)
Table 62. Middle East & Africa Prescription Weight Loss Medications Sales Market Share by Application (2017-2022)
Table 63. Middle East & Africa Prescription Weight Loss Medications Sales by Sales Channel (2017-2022) & (Units)
Table 64. Middle East & Africa Prescription Weight Loss Medications Sales Market Share by Sales Channel (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Prescription Weight Loss Medications
Table 66. Key Market Challenges & Risks of Prescription Weight Loss Medications
Table 67. Key Industry Trends of Prescription Weight Loss Medications
Table 68. Prescription Weight Loss Medications Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Prescription Weight Loss Medications Distributors List
Table 71. Prescription Weight Loss Medications Customer List
Table 72. Global Prescription Weight Loss Medications Sales Forecast by Region (2023-2028) & (Units)
Table 73. Global Prescription Weight Loss Medications Sales Market Forecast by Region
Table 74. Global Prescription Weight Loss Medications Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Prescription Weight Loss Medications Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Prescription Weight Loss Medications Sales Forecast by Country (2023-2028) & (Units)
Table 77. Americas Prescription Weight Loss Medications Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Prescription Weight Loss Medications Sales Forecast by Region (2023-2028) & (Units)
Table 79. APAC Prescription Weight Loss Medications Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Prescription Weight Loss Medications Sales Forecast by Country (2023-2028) & (Units)
Table 81. Europe Prescription Weight Loss Medications Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Prescription Weight Loss Medications Sales Forecast by Country (2023-2028) & (Units)
Table 83. Middle East & Africa Prescription Weight Loss Medications Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Prescription Weight Loss Medications Sales Forecast by Application (2023-2028) & (Units)
Table 85. Global Prescription Weight Loss Medications Sales Market Share Forecast by Application (2023-2028)
Table 86. Global Prescription Weight Loss Medications Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 87. Global Prescription Weight Loss Medications Revenue Market Share Forecast by Application (2023-2028)
Table 88. Global Prescription Weight Loss Medications Sales Forecast by Sales Channel (2023-2028) & (Units)
Table 89. Global Prescription Weight Loss Medications Sales Market Share Forecast by Sales Channel (2023-2028)
Table 90. Global Prescription Weight Loss Medications Revenue Forecast by Sales Channel (2023-2028) & ($ Millions)
Table 91. Global Prescription Weight Loss Medications Revenue Market Share Forecast by Sales Channel (2023-2028)
Table 92. Pfizer Basic Information, Prescription Weight Loss Medications Manufacturing Base, Sales Area and Its Competitors
Table 93. Pfizer Prescription Weight Loss Medications Product Offered
Table 94. Pfizer Prescription Weight Loss Medications Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 95. Pfizer Main Business
Table 96. Pfizer Latest Developments
Table 97. Bristol-Myers Squibb Basic Information, Prescription Weight Loss Medications Manufacturing Base, Sales Area and Its Competitors
Table 98. Bristol-Myers Squibb Prescription Weight Loss Medications Product Offered
Table 99. Bristol-Myers Squibb Prescription Weight Loss Medications Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 100. Bristol-Myers Squibb Main Business
Table 101. Bristol-Myers Squibb Latest Developments
Table 102. Roche Basic Information, Prescription Weight Loss Medications Manufacturing Base, Sales Area and Its Competitors
Table 103. Roche Prescription Weight Loss Medications Product Offered
Table 104. Roche Prescription Weight Loss Medications Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 105. Roche Main Business
Table 106. Roche Latest Developments
Table 107. Novo Nordisk Basic Information, Prescription Weight Loss Medications Manufacturing Base, Sales Area and Its Competitors
Table 108. Novo Nordisk Prescription Weight Loss Medications Product Offered
Table 109. Novo Nordisk Prescription Weight Loss Medications Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 110. Novo Nordisk Main Business
Table 111. Novo Nordisk Latest Developments
Table 112. GlaxoSmithKline Basic Information, Prescription Weight Loss Medications Manufacturing Base, Sales Area and Its Competitors
Table 113. GlaxoSmithKline Prescription Weight Loss Medications Product Offered
Table 114. GlaxoSmithKline Prescription Weight Loss Medications Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 115. GlaxoSmithKline Main Business
Table 116. GlaxoSmithKline Latest Developments
Table 117. Vivus Basic Information, Prescription Weight Loss Medications Manufacturing Base, Sales Area and Its Competitors
Table 118. Vivus Prescription Weight Loss Medications Product Offered
Table 119. Vivus Prescription Weight Loss Medications Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 120. Vivus Main Business
Table 121. Vivus Latest Developments
Table 122. Currax Pharmaceuticals Basic Information, Prescription Weight Loss Medications Manufacturing Base, Sales Area and Its Competitors
Table 123. Currax Pharmaceuticals Prescription Weight Loss Medications Product Offered
Table 124. Currax Pharmaceuticals Prescription Weight Loss Medications Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 125. Currax Pharmaceuticals Main Business
Table 126. Currax Pharmaceuticals Latest Developments
List of Figures
Figure 1. Picture of Prescription Weight Loss Medications
Figure 2. Prescription Weight Loss Medications Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Prescription Weight Loss Medications Sales Growth Rate 2017-2028 (Units)
Figure 7. Global Prescription Weight Loss Medications Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Prescription Weight Loss Medications Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Children & Teenagers
Figure 10. Product Picture of Adults
Figure 11. Global Prescription Weight Loss Medications Sales Market Share by Application in 2021
Figure 12. Global Prescription Weight Loss Medications Revenue Market Share by Application (2017-2022)
Figure 13. Prescription Weight Loss Medications Consumed in Online Sales
Figure 14. Global Prescription Weight Loss Medications Market: Online Sales (2017-2022) & (Units)
Figure 15. Prescription Weight Loss Medications Consumed in Offline Sales
Figure 16. Global Prescription Weight Loss Medications Market: Offline Sales (2017-2022) & (Units)
Figure 17. Global Prescription Weight Loss Medications Sales Market Share by Sales Channel (2017-2022)
Figure 18. Global Prescription Weight Loss Medications Revenue Market Share by Sales Channel in 2021
Figure 19. Prescription Weight Loss Medications Revenue Market by Company in 2021 ($ Million)
Figure 20. Global Prescription Weight Loss Medications Revenue Market Share by Company in 2021
Figure 21. Global Prescription Weight Loss Medications Sales Market Share by Geographic Region (2017-2022)
Figure 22. Global Prescription Weight Loss Medications Revenue Market Share by Geographic Region in 2021
Figure 23. Global Prescription Weight Loss Medications Sales Market Share by Region (2017-2022)
Figure 24. Global Prescription Weight Loss Medications Revenue Market Share by Country/Region in 2021
Figure 25. Americas Prescription Weight Loss Medications Sales 2017-2022 (Units)
Figure 26. Americas Prescription Weight Loss Medications Revenue 2017-2022 ($ Millions)
Figure 27. APAC Prescription Weight Loss Medications Sales 2017-2022 (Units)
Figure 28. APAC Prescription Weight Loss Medications Revenue 2017-2022 ($ Millions)
Figure 29. Europe Prescription Weight Loss Medications Sales 2017-2022 (Units)
Figure 30. Europe Prescription Weight Loss Medications Revenue 2017-2022 ($ Millions)
Figure 31. Middle East & Africa Prescription Weight Loss Medications Sales 2017-2022 (Units)
Figure 32. Middle East & Africa Prescription Weight Loss Medications Revenue 2017-2022 ($ Millions)
Figure 33. Americas Prescription Weight Loss Medications Sales Market Share by Country in 2021
Figure 34. Americas Prescription Weight Loss Medications Revenue Market Share by Country in 2021
Figure 35. United States Prescription Weight Loss Medications Revenue Growth 2017-2022 ($ Millions)
Figure 36. Canada Prescription Weight Loss Medications Revenue Growth 2017-2022 ($ Millions)
Figure 37. Mexico Prescription Weight Loss Medications Revenue Growth 2017-2022 ($ Millions)
Figure 38. Brazil Prescription Weight Loss Medications Revenue Growth 2017-2022 ($ Millions)
Figure 39. APAC Prescription Weight Loss Medications Sales Market Share by Region in 2021
Figure 40. APAC Prescription Weight Loss Medications Revenue Market Share by Regions in 2021
Figure 41. China Prescription Weight Loss Medications Revenue Growth 2017-2022 ($ Millions)
Figure 42. Japan Prescription Weight Loss Medications Revenue Growth 2017-2022 ($ Millions)
Figure 43. South Korea Prescription Weight Loss Medications Revenue Growth 2017-2022 ($ Millions)
Figure 44. Southeast Asia Prescription Weight Loss Medications Revenue Growth 2017-2022 ($ Millions)
Figure 45. India Prescription Weight Loss Medications Revenue Growth 2017-2022 ($ Millions)
Figure 46. Australia Prescription Weight Loss Medications Revenue Growth 2017-2022 ($ Millions)
Figure 47. Europe Prescription Weight Loss Medications Sales Market Share by Country in 2021
Figure 48. Europe Prescription Weight Loss Medications Revenue Market Share by Country in 2021
Figure 49. Germany Prescription Weight Loss Medications Revenue Growth 2017-2022 ($ Millions)
Figure 50. France Prescription Weight Loss Medications Revenue Growth 2017-2022 ($ Millions)
Figure 51. UK Prescription Weight Loss Medications Revenue Growth 2017-2022 ($ Millions)
Figure 52. Italy Prescription Weight Loss Medications Revenue Growth 2017-2022 ($ Millions)
Figure 53. Russia Prescription Weight Loss Medications Revenue Growth 2017-2022 ($ Millions)
Figure 54. Middle East & Africa Prescription Weight Loss Medications Sales Market Share by Country in 2021
Figure 55. Middle East & Africa Prescription Weight Loss Medications Revenue Market Share by Country in 2021
Figure 56. Egypt Prescription Weight Loss Medications Revenue Growth 2017-2022 ($ Millions)
Figure 57. South Africa Prescription Weight Loss Medications Revenue Growth 2017-2022 ($ Millions)
Figure 58. Israel Prescription Weight Loss Medications Revenue Growth 2017-2022 ($ Millions)
Figure 59. Turkey Prescription Weight Loss Medications Revenue Growth 2017-2022 ($ Millions)
Figure 60. GCC Country Prescription Weight Loss Medications Revenue Growth 2017-2022 ($ Millions)
Figure 61. Manufacturing Cost Structure Analysis of Prescription Weight Loss Medications in 2021
Figure 62. Manufacturing Process Analysis of Prescription Weight Loss Medications
Figure 63. Industry Chain Structure of Prescription Weight Loss Medications
Figure 64. Channels of Distribution
Figure 65. Distributors Profiles
The global digital pathology market was valued at $3,323 million in 2016, and is expected to reach $8,668 million by 2023, registering a CAGR of 14.8% during the forecast period. Digital pathology is defined as an image-based information setting enabled b...
The global regenerative medicine market was valued at $5,444 million in 2016, and is estimated to reach $39,325 million by 2023, registering a CAGR of 32.2% from 2017 to 2023. Regenerative medicines are used to repair, replace, and regenerate tissues & organs that are affected owin...
The medical robotics and computer-assisted surgery is a combination of equipment, accessories, software, and services that aid in performing different functions, such as robotic minimally invasive and non-invasive radiosurgeries, rehabilitation therapies, and hospital & pharmacy automation. Surgical robotics...